Comment on: Prescribing semaglutide for weight loss in non-diabetic, obese patients is associated with an increased risk of erectile dysfunction: a TriNetX database study
Crossref DOI link: https://doi.org/10.1038/s41443-024-00960-0
Published Online: 2024-08-09
Published Print: 2025-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Unal, Selman https://orcid.org/0000-0002-9000-304X
Text and Data Mining valid from 2024-08-09
Version of Record valid from 2024-08-09
Article History
Received: 1 July 2024
Revised: 15 July 2024
Accepted: 30 July 2024
First Online: 9 August 2024
Competing interests
: The author declares no competing interests.